Global Rotavirus Vaccine Market Overview:
Global Rotavirus Vaccine Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Rotavirus Vaccine Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Rotavirus Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Rotavirus Vaccine Market:
The Rotavirus Vaccine Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Rotavirus Vaccine Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Rotavirus Vaccine Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Rotavirus Vaccine market has been segmented into:
Rotarix
Rotavac
RotaTeq
By Application, Rotavirus Vaccine market has been segmented into:
Hospitals
Clinics
Academic And Research Institutions
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Rotavirus Vaccine market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Rotavirus Vaccine market.
Top Key Players Covered in Rotavirus Vaccine market are:
Merck & Co.
GlaxoSmithKline plc
Walvax Biotechnology Co.
Bharat Biotech International Limited
Institute of Vaccines and Medical Biologicals
Serum Institute of India Pvt. Ltd.
Chengdu Institute of Biological Products Co.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Rotavirus Vaccine Market by Type
4.1 Rotavirus Vaccine Market Snapshot and Growth Engine
4.2 Rotavirus Vaccine Market Overview
4.3 Rotarix
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Rotarix: Geographic Segmentation Analysis
4.4 Rotavac
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Rotavac: Geographic Segmentation Analysis
4.5 RotaTeq
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 RotaTeq: Geographic Segmentation Analysis
Chapter 5: Rotavirus Vaccine Market by Application
5.1 Rotavirus Vaccine Market Snapshot and Growth Engine
5.2 Rotavirus Vaccine Market Overview
5.3 Hospitals
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Hospitals: Geographic Segmentation Analysis
5.4 Clinics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Clinics: Geographic Segmentation Analysis
5.5 Academic And Research Institutions
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Academic And Research Institutions: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Rotavirus Vaccine Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MERCK & CO.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 GLAXOSMITHKLINE PLC
6.4 WALVAX BIOTECHNOLOGY CO.
6.5 BHARAT BIOTECH INTERNATIONAL LIMITED
6.6 INSTITUTE OF VACCINES AND MEDICAL BIOLOGICALS
6.7 SERUM INSTITUTE OF INDIA PVT. LTD.
6.8 CHENGDU INSTITUTE OF BIOLOGICAL PRODUCTS CO.
Chapter 7: Global Rotavirus Vaccine Market By Region
7.1 Overview
7.2. North America Rotavirus Vaccine Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Rotarix
7.2.4.2 Rotavac
7.2.4.3 RotaTeq
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Hospitals
7.2.5.2 Clinics
7.2.5.3 Academic And Research Institutions
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Rotavirus Vaccine Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Rotarix
7.3.4.2 Rotavac
7.3.4.3 RotaTeq
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Hospitals
7.3.5.2 Clinics
7.3.5.3 Academic And Research Institutions
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Rotavirus Vaccine Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Rotarix
7.4.4.2 Rotavac
7.4.4.3 RotaTeq
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Hospitals
7.4.5.2 Clinics
7.4.5.3 Academic And Research Institutions
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Rotavirus Vaccine Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Rotarix
7.5.4.2 Rotavac
7.5.4.3 RotaTeq
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Hospitals
7.5.5.2 Clinics
7.5.5.3 Academic And Research Institutions
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Rotavirus Vaccine Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Rotarix
7.6.4.2 Rotavac
7.6.4.3 RotaTeq
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Hospitals
7.6.5.2 Clinics
7.6.5.3 Academic And Research Institutions
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Rotavirus Vaccine Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Rotarix
7.7.4.2 Rotavac
7.7.4.3 RotaTeq
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Hospitals
7.7.5.2 Clinics
7.7.5.3 Academic And Research Institutions
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Rotavirus Vaccine Scope:
|
Report Data
|
Rotavirus Vaccine Market
|
|
Rotavirus Vaccine Market Size in 2025
|
USD XX million
|
|
Rotavirus Vaccine CAGR 2025 - 2032
|
XX%
|
|
Rotavirus Vaccine Base Year
|
2024
|
|
Rotavirus Vaccine Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Merck & Co., GlaxoSmithKline plc, Walvax Biotechnology Co., Bharat Biotech International Limited, Institute of Vaccines and Medical Biologicals, Serum Institute of India Pvt. Ltd., Chengdu Institute of Biological Products Co..
|
|
Key Segments
|
By Type
Rotarix
Rotavac
RotaTeq
By Applications
Hospitals
Clinics
Academic And Research Institutions
|
